Researchers using machine learning discovered that variations in microbial load in the gut, influenced by age, sex, diet, and ...

Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that the first patient has been ...

Many bacterial-linked illnesses, such as inflammatory bowel disease or colorectal cancer ... microbial load can be predicted for all adult human gut microbiome studies." The datasets the team ...

Many bacterial-linked illnesses, such as inflammatory bowel disease or colorectal cancer, are associated with an overgrowth ...

This can lead to several gastrointestinal disorders, such as colon cancer, inflammatory bowel disease, cystic fibrosis, and liver disease. This interplay between goblet cells and the gut microbiome is ...

Nanoparticles that turn inflammation into propulsion power deliver targeted IBD treatment, enhancing precision and efficacy.

Cambridge biopharma company Microbiotica reveals that the first patient has been dosed in its Phase 1b First-in-Human trial, ...

For example, a twin study by Willing et al. 10 in 2010 demonstrated a significant difference in the gut microbiome of ...

To illustrate this, imagine that only 1,000 bacteria live in your gut. In healthy individuals, this might include 10 bacteria ...

inflammatory bowel disease, cystic fibrosis, and liver diseases. Dr. Tonetti states, "This interplay between goblet cells and ...

Several studies suggest that diet plays a vital role in the etiopathogenesis of Crohn’s disease. Experts share their insights ...

inflammatory bowel disease, cystic fibrosis, and liver diseases. Dr Tonetti states, "This interplay between goblet cells and the gut microbiome is essential to sustaining both a strong immune defense ...